English
I-4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Isithombe Esifakiwe Sefekthri
  • I-4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

I-4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

Incazelo emfushane:

Igama Lekhemikhali: 4-Aminopyridine

I-CAS: 504-24-5

I-Assay: ≥99.5% (HPLC)

Ukubukeka: I-Crystalline Powder Emhlophe noma Ephuzi Kancane

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezwa Komkhiqizi, Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali: 4-Aminopyridine
I-CAS: 504-24-5

Chemical Properties:

Igama Lekhemikhali 4-Aminopyridine
Omqondofana 4-AP;4-Pyridinamine;I-Fampridine;I-Dalfampridine;i-p-aminopyridine;γ-Aminopyridine
Inombolo ye-CAS 504-24-5
Inombolo yeCAT I-RF-PI539
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C5H6N2
Isisindo samangqamuzana 94.12
Ukuncibilika Incibilika Emanzini, I-Ethanol
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder Emhlophe noma Ephuzi Kancane
Indlela Yokuhlola / Yokuhlaziya ≥99.5% (HPLC)
I-Melting Point 157.0~162.0℃
Amanzi (KF) ≤0.50%
Umlotha one-sulphate ≤0.20%
2-Aminopyridine ≤0.10%
3-Aminopyridine ≤0.10%
Ukungcola Okuphelele ≤0.50%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa Abalamuli Bezemithi;I-API

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-4-Aminopyridine (i-CAS: 504-24-5) ingenye yama-amine amathathu e-isomeri ye-pyridine, iyinhlanganisela ehlanzekile kakhulu, yokwenziwa, ne-biologically esebenzayo, esetshenziswa kabanzi ekuhlanganiseni kwe-organic, ukuhlanganiswa kwemithi ephakathi kwemithi kanye ne-Active Pharmaceutical Ingredient (API ) ukuhlanganisa.I-4-Aminopyridine (i-4-AP, i-Fampridine, i-Dalfampridine) isetshenziswa njengethuluzi lokucwaninga ekuboniseni izinhlobo ezincane zesiteshi se-potassium.Ibuye isetshenziswe njengesidakamizwa, ukuphatha ezinye zezimpawu ze-multiple sclerosis, futhi iboniswa ukuthuthukiswa okuphawulekayo kokuhamba kwabantu abadala abanezinhlobonhlobo eziningana zesifo.I-US Food and Drug Administration (FDA) yagunyaza inhlanganisela ngoJanuwari 22, 2010. I-Fampridine iphinde imakethwe e-United States yi-Acorda Therapeutics kanye ne-Fampyra e-European Union, Canada, nase-Australia.

Bhala umyalezo wakho lapha futhi usithumelele wona